Law360, New York (November 10, 2006, 12:00 AM EST) -- In a bid to quell escalating concerns over medical device regulation, the U.S. Food and Drug Administration on Thursday jumped into action, revealing plans to bolster the way it monitors the safety of products such as stents, pacemakers, and implantable defibrillators after they reach the marketplace.
The agency said its efforts will increase its ability to identify, analyze, and act on the risks that may be posed by the thousands of devices used by health professionals and consumers.
"Many of today's medical devices are smaller and...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.